Skip to main content
Top
Published in: Journal of Translational Medicine 1/2019

Open Access 01-12-2019 | Esophageal Cancer | Research

A world map of esophagus cancer research: a critical accounting

Authors: Doris Klingelhöfer, Yun Zhu, Markus Braun, Dörthe Brüggmann, Norman Schöffel, David A. Groneberg

Published in: Journal of Translational Medicine | Issue 1/2019

Login to get access

Abstract

Background

Esophageal cancer (EC) is one of the deadliest cancers worldwide. The contemporary strong increase of the adenocarcinomas in Western countries and the high mortality rates require the intensification of prospective multinational studies.

Methods

Therefore, this global health issue has been chosen for the bibliometric review of the global publication output. As source for meta and citation data, the Web of Science has been used and Density Equalizing Maps were applied for visualization.

Results

17,387 articles on EC could be identified. The years with publication and citation maxima correspond to the appearance of the most prolific articles. China is the most publishing country, followed by Japan and the USA. Germany and the UK ranked 4th and 5th. The analysis of the ratios articles and socio-economic parameters emphasizes the leading position of the Scandinavian countries and Japan. Here, the high-income countries come out on top. The high incidence regions are mainly represented by Chinese and Japanese research. The association of the publication output and the overall research funding could be shown.

Conclusions

A strengthened international network increasingly consisting of the scientifically best positioned countries as well as more of the high incidence countries worldwide is mandatory for future research. The findings deliver scientists, clinicians and decision makers backgrounds for future decisions all over the world.
Literature
1.
go back to reference Karamanou M, Markatos K, Papaioannou TG, Zografos G, Androutsos G. Hallmarks in history of esophageal carcinoma. J BUON. 2017;22(4):1088–91.PubMed Karamanou M, Markatos K, Papaioannou TG, Zografos G, Androutsos G. Hallmarks in history of esophageal carcinoma. J BUON. 2017;22(4):1088–91.PubMed
2.
go back to reference Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.CrossRef Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.CrossRef
3.
go back to reference Klevebro F, Ekman S, Nilsson M. Current trends in multimodality treatment of esophageal and gastroesophageal junction cancer—review article. Surg Oncol. 2017;26(3):290–5.CrossRef Klevebro F, Ekman S, Nilsson M. Current trends in multimodality treatment of esophageal and gastroesophageal junction cancer—review article. Surg Oncol. 2017;26(3):290–5.CrossRef
4.
go back to reference Hou XB, Wen JX, Ren ZP, Zhang GL. Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer. Oncotarget. 2017;8(26):43571–8.CrossRef Hou XB, Wen JX, Ren ZP, Zhang GL. Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer. Oncotarget. 2017;8(26):43571–8.CrossRef
5.
go back to reference Visser E, Franken IA, Brosens LAA, Ruurda JP, van Hillegersberg R. Prognostic gene expression profiling in esophageal cancer: a systematic review. Oncotarget. 2017;8(3):5566–77.CrossRef Visser E, Franken IA, Brosens LAA, Ruurda JP, van Hillegersberg R. Prognostic gene expression profiling in esophageal cancer: a systematic review. Oncotarget. 2017;8(3):5566–77.CrossRef
6.
go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef
7.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRef
8.
go back to reference Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomark Prev. 2010;19(6):1468–70.CrossRef Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomark Prev. 2010;19(6):1468–70.CrossRef
9.
go back to reference Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.CrossRef Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.CrossRef
10.
go back to reference Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6.CrossRef Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6.CrossRef
11.
go back to reference Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89(17):1277–84.CrossRef Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89(17):1277–84.CrossRef
12.
go back to reference Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case–control study. BMJ. 2009;338:b929.CrossRef Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case–control study. BMJ. 2009;338:b929.CrossRef
13.
go back to reference Liu J, Wang J, Leng Y, Lv C. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013;133(2):473–85.CrossRef Liu J, Wang J, Leng Y, Lv C. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013;133(2):473–85.CrossRef
14.
go back to reference Akhtar S, Sheikh AA, Qureshi HU. Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in South Asians: a multicentre case–control study. Eur J Cancer. 2012;48(5):655–61.CrossRef Akhtar S, Sheikh AA, Qureshi HU. Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in South Asians: a multicentre case–control study. Eur J Cancer. 2012;48(5):655–61.CrossRef
15.
go back to reference Lopez-Lazaro M. Understanding why aspirin prevents cancer and why consuming very hot beverages and foods increases esophageal cancer risk. Controlling the division rates of stem cells is an important strategy to prevent cancer. Oncoscience. 2015;2(10):849–56.PubMedPubMedCentral Lopez-Lazaro M. Understanding why aspirin prevents cancer and why consuming very hot beverages and foods increases esophageal cancer risk. Controlling the division rates of stem cells is an important strategy to prevent cancer. Oncoscience. 2015;2(10):849–56.PubMedPubMedCentral
16.
go back to reference Mund ME, Gyo C, Bruggmann D, Quarcoo D, Groneberg DA. Acetylsalicylic acid as a potential pediatric health hazard: legislative aspects concerning accidental intoxications in the European Union. J Occup Med Toxicol. 2016;11:5.CrossRef Mund ME, Gyo C, Bruggmann D, Quarcoo D, Groneberg DA. Acetylsalicylic acid as a potential pediatric health hazard: legislative aspects concerning accidental intoxications in the European Union. J Occup Med Toxicol. 2016;11:5.CrossRef
17.
go back to reference Chang-Claude J, Becher H, Blettner M, Qiu S, Yang G, Wahrendorf J. Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol. 1997;26(6):1159–65.CrossRef Chang-Claude J, Becher H, Blettner M, Qiu S, Yang G, Wahrendorf J. Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol. 1997;26(6):1159–65.CrossRef
18.
go back to reference Mohner M, Wendt A. A diagnostic bias might be a much simpler explanation for the apparently elevated risk for nasopharyngeal cancer with respect to formaldehyde. J Occup Med Toxicol. 2016;11:3.CrossRef Mohner M, Wendt A. A diagnostic bias might be a much simpler explanation for the apparently elevated risk for nasopharyngeal cancer with respect to formaldehyde. J Occup Med Toxicol. 2016;11:3.CrossRef
19.
go back to reference Romaniuk A, Lyndin M, Sikora V, Lyndina Y, Romaniuk S, Sikora K. Heavy metals effect on breast cancer progression. J Occup Med Toxicol. 2017;12:9.CrossRef Romaniuk A, Lyndin M, Sikora V, Lyndina Y, Romaniuk S, Sikora K. Heavy metals effect on breast cancer progression. J Occup Med Toxicol. 2017;12:9.CrossRef
20.
go back to reference Castro C, Peleteiro B, Lunet N. Modifiable factors and esophageal cancer: a systematic review of published meta-analyses. J Gastroenterol. 2017;53(1):37–51.CrossRef Castro C, Peleteiro B, Lunet N. Modifiable factors and esophageal cancer: a systematic review of published meta-analyses. J Gastroenterol. 2017;53(1):37–51.CrossRef
21.
go back to reference Budnik LT, Baur X, Harth V, Hahn A. Alternative drugs go global: possible lead and/or mercury intoxication from imported natural health products and a need for scientifically evaluated poisoning monitoring from environmental exposures. J Occup Med Toxicol. 2016;11:6.CrossRef Budnik LT, Baur X, Harth V, Hahn A. Alternative drugs go global: possible lead and/or mercury intoxication from imported natural health products and a need for scientifically evaluated poisoning monitoring from environmental exposures. J Occup Med Toxicol. 2016;11:6.CrossRef
22.
go back to reference Groneberg-Kloft B, Fischer TC, Quarcoo D, Scutaru C. New quality and quantity indices in science (NewQIS): the study protocol of an international project. J Occup Med Toxicol. 2009;4:16.CrossRef Groneberg-Kloft B, Fischer TC, Quarcoo D, Scutaru C. New quality and quantity indices in science (NewQIS): the study protocol of an international project. J Occup Med Toxicol. 2009;4:16.CrossRef
23.
go back to reference van Eck NJ, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics. 2017;111(2):1053–70.CrossRef van Eck NJ, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics. 2017;111(2):1053–70.CrossRef
25.
go back to reference Hirsch JE. Does the H index have predictive power? Proc Natl Acad Sci USA. 2007;104(49):19193–8.CrossRef Hirsch JE. Does the H index have predictive power? Proc Natl Acad Sci USA. 2007;104(49):19193–8.CrossRef
28.
go back to reference Gastner MT, Newman ME. From the cover: diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci USA. 2004;101(20):7499–504.CrossRef Gastner MT, Newman ME. From the cover: diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci USA. 2004;101(20):7499–504.CrossRef
29.
go back to reference Lopez-Illescas C, Anegon FD, Moed HF. Comparing bibliometric country-by-country rankings derived from the Web of Science and Scopus: the effect of poorly cited journals in oncology. J Inf Sci. 2009;35(2):244–56.CrossRef Lopez-Illescas C, Anegon FD, Moed HF. Comparing bibliometric country-by-country rankings derived from the Web of Science and Scopus: the effect of poorly cited journals in oncology. J Inf Sci. 2009;35(2):244–56.CrossRef
30.
go back to reference Kulkarni AV, Aziz B, Shams I, Busse JW. Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals. JAMA. 2009;302(10):1092–6.CrossRef Kulkarni AV, Aziz B, Shams I, Busse JW. Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals. JAMA. 2009;302(10):1092–6.CrossRef
31.
go back to reference Aksnes DW. A macro study of self-citation. Scientometrics. 2003;56(2):235–46.CrossRef Aksnes DW. A macro study of self-citation. Scientometrics. 2003;56(2):235–46.CrossRef
32.
go back to reference Baldi S. Normative versus social constructivist processes in the allocation of citations: a network-analytic model. Am Sociol Rev. 1998;63(6):829–46.CrossRef Baldi S. Normative versus social constructivist processes in the allocation of citations: a network-analytic model. Am Sociol Rev. 1998;63(6):829–46.CrossRef
34.
go back to reference Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83(10):2049–53.CrossRef Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83(10):2049–53.CrossRef
35.
go back to reference Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97.CrossRef Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97.CrossRef
36.
go back to reference Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593–8.CrossRef Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593–8.CrossRef
37.
go back to reference van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.CrossRef van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.CrossRef
38.
go back to reference Chen W, Zheng R, Zeng H, Zhang S. The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer. 2015;34(11):502–7.PubMed Chen W, Zheng R, Zeng H, Zhang S. The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer. 2015;34(11):502–7.PubMed
39.
go back to reference Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.CrossRef Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.CrossRef
40.
go back to reference Song H, Zhu JW, Lu DH, Fang F, Ye WM, Lundell L, et al. Psychiatric morbidity and its impact on surgical outcomes for esophageal and gastric cancer patients: a nationwide cohort study. Oncotarget. 2017;8(46):81305–14.PubMedPubMedCentral Song H, Zhu JW, Lu DH, Fang F, Ye WM, Lundell L, et al. Psychiatric morbidity and its impact on surgical outcomes for esophageal and gastric cancer patients: a nationwide cohort study. Oncotarget. 2017;8(46):81305–14.PubMedPubMedCentral
41.
go back to reference Xie SH, Wahlin K, Lagergren J. Cause of death in patients diagnosed with esophageal cancer in Sweden: a population-based study. Oncotarget. 2017;8(31):51800–9.PubMedPubMedCentral Xie SH, Wahlin K, Lagergren J. Cause of death in patients diagnosed with esophageal cancer in Sweden: a population-based study. Oncotarget. 2017;8(31):51800–9.PubMedPubMedCentral
42.
go back to reference Xie SH, Jernberg T, Mattsson F, Lagergren J. Digitalis use and risk of gastrointestinal cancers: a nationwide population-based cohort study. Oncotarget. 2017;8(21):34727–35.CrossRef Xie SH, Jernberg T, Mattsson F, Lagergren J. Digitalis use and risk of gastrointestinal cancers: a nationwide population-based cohort study. Oncotarget. 2017;8(21):34727–35.CrossRef
43.
go back to reference Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993–2001. Jpn J Clin Oncol. 2008;38(7):464–8.CrossRef Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993–2001. Jpn J Clin Oncol. 2008;38(7):464–8.CrossRef
44.
go back to reference Man JP, Weinkauf JG, Tsang M, Sin DD. Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked general medical journals. Eur J Epidemiol. 2004;19(8):811–7.CrossRef Man JP, Weinkauf JG, Tsang M, Sin DD. Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked general medical journals. Eur J Epidemiol. 2004;19(8):811–7.CrossRef
45.
go back to reference Schmidt S, Bundschuh M, Scutaru C, Klingelhoefer D, Groneberg DA, Gerber A. Hepatitis B: global scientific development from a critical point of view. J Viral Hepatitis. 2014;21(11):786–93.CrossRef Schmidt S, Bundschuh M, Scutaru C, Klingelhoefer D, Groneberg DA, Gerber A. Hepatitis B: global scientific development from a critical point of view. J Viral Hepatitis. 2014;21(11):786–93.CrossRef
46.
go back to reference Groneberg DA, Weber E, Gerber A, Fischer A, Klingelhoefer D, Brueggmann D. Density equalizing mapping of the global tuberculosis research architecture. Tuberculosis. 2015;95(4):515–22.CrossRef Groneberg DA, Weber E, Gerber A, Fischer A, Klingelhoefer D, Brueggmann D. Density equalizing mapping of the global tuberculosis research architecture. Tuberculosis. 2015;95(4):515–22.CrossRef
47.
go back to reference Groneberg-Kloft B, Klingelhoefer D, Zitnik SE, Scutaru C. Traffic medicine-related research: a scientometric analysis. BMC Public Health. 2013;13:13.CrossRef Groneberg-Kloft B, Klingelhoefer D, Zitnik SE, Scutaru C. Traffic medicine-related research: a scientometric analysis. BMC Public Health. 2013;13:13.CrossRef
48.
go back to reference Carter AJ, Nguyen CN. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding. BMC Public Health. 2012;12:526.CrossRef Carter AJ, Nguyen CN. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding. BMC Public Health. 2012;12:526.CrossRef
49.
go back to reference Carter AJ, Delarosa B, Hur H. An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values. Health Res Policy Syst. 2015;13:62.CrossRef Carter AJ, Delarosa B, Hur H. An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values. Health Res Policy Syst. 2015;13:62.CrossRef
Metadata
Title
A world map of esophagus cancer research: a critical accounting
Authors
Doris Klingelhöfer
Yun Zhu
Markus Braun
Dörthe Brüggmann
Norman Schöffel
David A. Groneberg
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2019
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-019-1902-7

Other articles of this Issue 1/2019

Journal of Translational Medicine 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine